Kura Oncology, Inc., 2026-11-18
A new SEC Form D private-offering notice from San Diego, CA, a $25,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing precision medicines targeting cancer signaling pathways for blood cancers and solid tumors.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Nexus Networks, Inc., 2026-11-18, $47.5M, San Francisco, CA
- Laza Medical, Inc., 2026-11-19, $115M, Campbell, CA
- Robot.com Holdings, Inc., 2026-11-18, $25M, San Francisco, CA
- Linnaeus Therapeutics, Inc., 2026-11-18, $10M, Haddonfield, NJ
- Galvanize Therapeutics, Inc., 2026-11-18, $136.2M, Redwood City, CA
- Ansa Biotechnologies, Inc., 2026-11-18, $71.9M, Emeryville, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.